Dongkook Pharmaceutical Co., Ltd. logo

Dongkook Pharmaceutical Co., Ltd. (086450)

Market Closed
14 Oct, 06:30 AM
KOSDAQ KOSDAQ
₩
24,250. 00
+1,000
+4.3011%
₩
- Market Cap
- P/E Ratio
720% Div Yield
856,563 Volume
- Eps
₩ 23,250
Previous Close
Add Transaction
Day Range
22,450 24,850
Year Range
14,400 20,450
Want to track 086450 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

086450 closed yesterday higher at ₩24,250, an increase of 4.3011% from Tuesday's close, completing a monthly increase of 41.317% or ₩7,090. Over the past 12 months, 086450 stock gained 41.317%.
086450 pays dividends to its shareholders, with the most recent payment made on Apr 01, 2026. The next estimated payment will be in In 5 months on Apr 01, 2027 for a total of ₩200.
The last earnings report, released on Mar 11, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 148.6543%, based on the last three reports.
Dongkook Pharmaceutical Co., Ltd. has completed 3 stock splits, with the recent split occurring on Sep 10, 2020.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on KRX SM (KRW).

086450 Chart

Dongkook Pharmaceutical Co., Ltd. (086450) FAQ

What is the stock price today?

The current price is ₩24,250.00.

On which exchange is it traded?

Dongkook Pharmaceutical Co., Ltd. is listed on KOSDAQ.

What is its stock symbol?

The ticker symbol is 086450.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 720%.

What is its market cap?

As of today, no market cap data is available.

Has Dongkook Pharmaceutical Co., Ltd. ever had a stock split?

Dongkook Pharmaceutical Co., Ltd. had 3 splits and the recent split was on Sep 10, 2020.

Dongkook Pharmaceutical Co., Ltd. Profile

Pharmaceuticals Industry
Healthcare Sector
- CEO
KOSDAQ Exchange
KR7086450004 ISIN
South Korea Country
- Employees
- Last Dividend
24 Aug 2020 Last Split
- IPO Date

Contact Information

Address: -
Phone: -